StonvexLoading…
StonvexStonvexStonvexCore line items from BIOF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2019 2019-12-31 |
|---|---|
Revenue | $60.00K |
Operating Income | $-1.78M |
Net Income | $1.01M |
EPS (Diluted) | $0.01 |
Total Assets | $609.59K |
Total Liabilities | $3.94M |
Cash & Equivalents | $110.63K |
Free Cash Flow OCF − CapEx | Not available |
Shares Outstanding | 219.51M |